Skip to main content
Premium Trial:

Request an Annual Quote

Cepheid Licenses Patents to Maker of Handheld Bioagent Detection Devices

NEW YORK, Dec. 12 - Cepheid granted Baltimore-based Environmental Technologies Group a sublicense to key patents for development of rapid, hand-held DNA analysis systems for bioagent detection, the company said on Wednesday.

 

The sublicense is worldwide and non-exclusive, and grants ETG rights to patented component designs for performing and monitoring analytical reactions, such as PCR, used in DNA detection on a hand-held device using battery power. Cepheid retains rights to commercialize hand-held systems for all other DNA-testing applications, including environmental testing and veterinary diagnostics, according to the company.

 

Cepheid and ETG have a US Department of Defense contract to deliver hand-held biological detection devices.

 

Cepheid, based in Sunnyvale, Calif., will receive royalties on ETG sales of the hand-held bioagent detection device. Financial details of the agreement were not disclosed.

 

"Cepheid views this new agreement as a continuation of our partnership with ETG in the area of bioagent detection for both military and homeland security applications," Tom Gutshall, CEO of Cepheid, said in a statement. "This agreement leverages the combined strengths of both companies across a range of markets, and presents a valuable opportunity for Cepheid to apply our core patents to development of a hand-held device."

 

Cepheid holds the exclusive license to these analytical reaction design patents from the University of California and Lawrence Livermore National Laboratories.

 

 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.